Mizolastine |
A histamine H1 receptor antagonist (Ki = 0.001 µM); selective for hi… |
5 g |
9000566-5 |
More Info
|
Mizolastine |
A histamine H1 receptor antagonist (Ki = 0.001 µM); selective for hi… |
500 mg |
9000566-500 |
More Info
|
Mizoribine |
An imidazole nucleoside with immunosuppressive properties; inhibits T cell… |
10 mg |
23128-10 |
More Info
|
Mizoribine |
An imidazole nucleoside with immunosuppressive properties; inhibits T cell… |
100 mg |
23128-100 |
More Info
|
Mizoribine |
An imidazole nucleoside with immunosuppressive properties; inhibits T cell… |
25 mg |
23128-25 |
More Info
|
Mizoribine |
An imidazole nucleoside with immunosuppressive properties; inhibits T cell… |
50 mg |
23128-50 |
More Info
|
MJ15 |
A potent CB1 receptor antagonist (IC50 = 118.9 pM; Ki = 27.2 pM for rat CB… |
1 mg |
11956-1 |
More Info
|
MJ15 |
A potent CB1 receptor antagonist (IC50 = 118.9 pM; Ki = 27.2 pM for rat CB… |
10 mg |
11956-10 |
More Info
|
MJ15 |
A potent CB1 receptor antagonist (IC50 = 118.9 pM; Ki = 27.2 pM for rat CB… |
25 mg |
11956-25 |
More Info
|
MJ15 |
A potent CB1 receptor antagonist (IC50 = 118.9 pM; Ki = 27.2 pM for rat CB… |
5 mg |
11956-5 |
More Info
|
MJ33 (lithium salt) |
A selective, reversible inhibitor of the acidic, calcium-independent (ai)P… |
1 mg |
90001844-1 |
More Info
|
MJ33 (lithium salt) |
A selective, reversible inhibitor of the acidic, calcium-independent (ai)P… |
10 mg |
90001844-10 |
More Info
|
MJ33 (lithium salt) |
A selective, reversible inhibitor of the acidic, calcium-independent (ai)P… |
25 mg |
90001844-25 |
More Info
|
MJ33 (lithium salt) |
A selective, reversible inhibitor of the acidic, calcium-independent (ai)P… |
5 mg |
90001844-5 |
More Info
|
MJN110 |
An inhibitor of MAGL (IC50 = 9.1 nM) and to a lesser extent ABHD6 with pot… |
10 mg |
17583-10 |
More Info
|
MJN110 |
An inhibitor of MAGL (IC50 = 9.1 nM) and to a lesser extent ABHD6 with pot… |
100 mg |
17583-100 |
More Info
|
MJN110 |
An inhibitor of MAGL (IC50 = 9.1 nM) and to a lesser extent ABHD6 with pot… |
25 mg |
17583-25 |
More Info
|
MJN110 |
An inhibitor of MAGL (IC50 = 9.1 nM) and to a lesser extent ABHD6 with pot… |
5 mg |
17583-5 |
More Info
|
MJN228 |
A selective ligand for the lipid-binding protein NUCB1, blocking binding o… |
1 mg |
18275-1 |
More Info
|
MJN228 |
A selective ligand for the lipid-binding protein NUCB1, blocking binding o… |
10 mg |
18275-10 |
More Info
|
MJN228 |
A selective ligand for the lipid-binding protein NUCB1, blocking binding o… |
25 mg |
18275-25 |
More Info
|
MJN228 |
A selective ligand for the lipid-binding protein NUCB1, blocking binding o… |
5 mg |
18275-5 |
More Info
|
MK-0457 |
A potent pan-Aurora kinase inhibitor that favors Aurora A (Ki = 0.6 nM) ov… |
100 mg |
13600-100 |
More Info
|
MK-0457 |
A potent pan-Aurora kinase inhibitor that favors Aurora A (Ki = 0.6 nM) ov… |
25 mg |
13600-25 |
More Info
|
MK-0457 |
A potent pan-Aurora kinase inhibitor that favors Aurora A (Ki = 0.6 nM) ov… |
250 mg |
13600-250 |
More Info
|
MK-0457 |
A potent pan-Aurora kinase inhibitor that favors Aurora A (Ki = 0.6 nM) ov… |
50 mg |
13600-50 |
More Info
|
MK-0524 |
A potent, selective DP1 receptor antagonist that binds DP1 and DP2 recepto… |
1 mg |
10009835-1 |
More Info
|
MK-0524 |
A potent, selective DP1 receptor antagonist that binds DP1 and DP2 recepto… |
10 mg |
10009835-10 |
More Info
|
MK-0524 |
A potent, selective DP1 receptor antagonist that binds DP1 and DP2 recepto… |
25 mg |
10009835-25 |
More Info
|
MK-0524 |
A potent, selective DP1 receptor antagonist that binds DP1 and DP2 recepto… |
5 mg |
10009835-5 |
More Info
|
MK-0557 |
A potent antagonist of NPY receptor Y5 (Kis = 1.3, 0.79, 0.74, and 1.4 nM… |
1 mg |
22134-1 |
More Info
|
MK-0557 |
A potent antagonist of NPY receptor Y5 (Kis = 1.3, 0.79, 0.74, and 1.4 nM… |
10 mg |
22134-10 |
More Info
|
MK-0557 |
A potent antagonist of NPY receptor Y5 (Kis = 1.3, 0.79, 0.74, and 1.4 nM… |
25 mg |
22134-25 |
More Info
|
MK-0557 |
A potent antagonist of NPY receptor Y5 (Kis = 1.3, 0.79, 0.74, and 1.4 nM… |
5 mg |
22134-5 |
More Info
|
MK-0591 |
An inhibitor of FLAP (IC50 = 1.6 nM for the human enzyme); inhibits LTB4 b… |
1 mg |
37322-1 |
More Info
|
MK-0591 |
An inhibitor of FLAP (IC50 = 1.6 nM for the human enzyme); inhibits LTB4 b… |
10 mg |
37322-10 |
More Info
|
MK-0591 |
An inhibitor of FLAP (IC50 = 1.6 nM for the human enzyme); inhibits LTB4 b… |
25 mg |
37322-25 |
More Info
|
MK-0591 |
An inhibitor of FLAP (IC50 = 1.6 nM for the human enzyme); inhibits LTB4 b… |
5 mg |
37322-5 |
More Info
|
MK-0752 |
A potent, reversible inhibitor of γ-secretase, reducing the cleavage… |
1 mg |
16706-1 |
More Info
|
MK-0752 |
A potent, reversible inhibitor of γ-secretase, reducing the cleavage… |
10 mg |
16706-10 |
More Info
|
MK-0752 |
A potent, reversible inhibitor of γ-secretase, reducing the cleavage… |
5 mg |
16706-5 |
More Info
|
MK-0812 |
A CCR2 antagonist (IC50 = 5 nM for the human receptor); inhibits mammosphe… |
1 mg |
21803-1 |
More Info
|
MK-0812 |
A CCR2 antagonist (IC50 = 5 nM for the human receptor); inhibits mammosphe… |
10 mg |
21803-10 |
More Info
|
MK-0812 |
A CCR2 antagonist (IC50 = 5 nM for the human receptor); inhibits mammosphe… |
5 mg |
21803-5 |
More Info
|
MK-0941 |
A glucokinase activator (EC50s = 0.24 and 0.065 µM at low (2.5 mM) a… |
1 mg |
25642-1 |
More Info
|
MK-0941 |
A glucokinase activator (EC50s = 0.24 and 0.065 µM at low (2.5 mM) a… |
10 mg |
25642-10 |
More Info
|
MK-0941 |
A glucokinase activator (EC50s = 0.24 and 0.065 µM at low (2.5 mM) a… |
25 mg |
25642-25 |
More Info
|
MK-0941 |
A glucokinase activator (EC50s = 0.24 and 0.065 µM at low (2.5 mM) a… |
5 mg |
25642-5 |
More Info
|
MK-0974 |
A CGRP receptor antagonist (Ki = 0.77 µM); binds selectively to the… |
1 mg |
23960-1 |
More Info
|
MK-0974 |
A CGRP receptor antagonist (Ki = 0.77 µM); binds selectively to the… |
10 mg |
23960-10 |
More Info
|